NCT07516353
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia ,Lymphomas, +32 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Rhabdomyosarcoma. Study availability and eligibility vary by location and protocol.
NCT07516353
NCT07355855
NCT07224568
NCT06932861
Not specified
NCT06822842
Not specified
NCT06029465
NCT02945800
NCT01625351
NCT02415816
NCT01858168